Successful tyrosine kinase inhibitor therapy in a refractory B-cell precursor acute lymphoblastic leukemia with EBF1-PDGFRB fusion
Etienne Lengline,
Kheïra Beldjord,
Hervé Dombret,
Jean Soulier,
Nicolas Boissel,
Emmanuelle Clappier
Affiliations
Etienne Lengline
Adolescents and Young Adults Hematology Unit, APHP, Saint-Louis Hospital, Paris, France;EA-3518, Institute of Hematology (IUH), Univ Paris Diderot, Sorbonne Paris Cité, France
Kheïra Beldjord
Hematology Laboratory, APHP, Saint-Louis Hospital, Paris, France
Hervé Dombret
Adolescents and Young Adults Hematology Unit, APHP, Saint-Louis Hospital, Paris, France;EA-3518, Institute of Hematology (IUH), Univ Paris Diderot, Sorbonne Paris Cité, France
Jean Soulier
Hematology Laboratory, APHP, Saint-Louis Hospital, Paris, France;U944 INSERM, Institute of Hematology (IUH), Univ Paris Diderot, Sorbonne Paris Cité, France
Nicolas Boissel
Adolescents and Young Adults Hematology Unit, APHP, Saint-Louis Hospital, Paris, France;EA-3518, Institute of Hematology (IUH), Univ Paris Diderot, Sorbonne Paris Cité, France
Emmanuelle Clappier
Hematology Laboratory, APHP, Saint-Louis Hospital, Paris, France;U944 INSERM, Institute of Hematology (IUH), Univ Paris Diderot, Sorbonne Paris Cité, France;Department of Genetics, Robert Debré Hospital, Paris, France